Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesIndications for biopsy and the current status of focal therapy for renal tumoursPotential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell CarcinomaUrinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.Tumor size, stage and grade alterations of urinary peptidome in RCC.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Deciphering the complexity of the cancer proteome for diagnostic applications.The proteomic landscape of renal tumors.Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.Prediction of Proteases Involved in Peptide Generation.Urinary CE-MS peptide marker pattern for detection of solid tumors.The potential of liquid biopsies for the early detection of cancer.Epidemiology and screening for renal cancer
P2860
Q26749401-E0731CF1-5512-4898-A8D9-09A02A50062CQ26773659-9942E0A9-6228-4DB7-987B-A907FAABD4CAQ26777900-567BBE5A-4B41-4B05-9DD5-D59A5E8A636FQ34155959-B7679086-6522-4EB8-8A09-2A2F4E25F88FQ35813526-69ADF627-96AF-47C6-95CB-6D17F1CC56A6Q35862682-39553037-E507-4D1B-B9BE-2760F5560268Q37714579-B827D353-1B07-45D7-B6A6-4614FA5C85B9Q38217103-27E96D28-5D1C-409D-8DCD-E77C2376820FQ38340351-0FAFFA5B-8FB3-4D0E-B765-956D2FC7D24BQ38676337-10170CAF-6189-45A1-9E84-2D37286EFA58Q38803559-8CC1EA3C-9BC2-4332-BDD7-CA0B0F46BEADQ38906256-1C033E4B-5D9A-4C84-B275-E4A2D4560623Q39243268-AAAB7CD2-4A37-4B34-83EF-E8748792CB0BQ50256258-8C3587FA-1053-4612-90CE-627DCAE3A06DQ51094837-23033B61-243C-4EB3-AB96-12D134A02BE0Q52723689-53028FBF-A79C-4BFA-BFE7-6407555FAB7CQ55269325-287CD8B4-6D6B-490A-9ECC-A0B3D7EAF836Q57640122-37B112F2-CBDB-4987-8A73-A9A65781957E
P2860
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en-gb
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@nl
type
label
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en-gb
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@nl
prefLabel
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en-gb
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@nl
P2093
P50
P1476
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
@en
P2093
Axel S Merseburger
Dan Theodorescu
Holger Husi
Jonathan J Cartledge
Korbinian Brand
Markus A Kuczyk
Mohammed Dakna
William Mullen
P356
10.1016/J.JPROT.2013.12.010
P50
P577
2013-12-25T00:00:00Z